Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Noninvasive Evaluation of Fetal Hyperinsulinemia With Ultrasound Radiomics

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this observational study is to compare fetal liver ultrasound radiomics between pregnancies complicated by type 1 diabetes and healthy controls. The main questions it aims to answer are: * Are fetal liver ultrasound radiomic features reproducible? * Does fetal liver ultrasound radiomics differ between pregnancies complicated by type 1 diabetes and healthy controls? Participants will undergo ultrasound examination to collect ultrasound data for the analyses.

Who May Be Eligible (Plain English)

Who May Qualify: - Age between 18-45 years - Capable to give an willing to sign a consent form - Singleton pregnancy - Planning to deliver in Turku University Hospital - Maternal BMI \< 40 - Gestational age should be confirmed by first trimester ultrasound - Normal oral glucose tolerance test (OGTT) at 24-28 gestational weeks in controls Who Should NOT Join This Trial: - Major fetal chromosomal, genetic, or structural anomaly - Fetal growth restriction, or birth weight \< 10th centile - Birth weight \> 90th centile or polyhydramnios in the controls - Non-reassuring fetal status requiring immediate treatment, or intrauterine fetal demise - Verified fetal infection (e.g. cytomegalovirus, toxoplasma, hepatitis B and C), excluding bacterial infection due to intrapartum chorioamnionitis - Placenta accreta spectrum disorder - Major maternal medical condition requiring systemic pharmacological treatment, other than non-severe hypertension, hypothyroidism, asthma, mild psychiatric disorders, etc. - Alcohol or tobacco use, or substance abuse in pregnancy Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age between 18-45 years * Capable to give an informed consent * Singleton pregnancy * Planning to deliver in Turku University Hospital * Maternal BMI \< 40 * Gestational age should be confirmed by first trimester ultrasound * Normal oral glucose tolerance test (OGTT) at 24-28 gestational weeks in controls Exclusion Criteria: * Major fetal chromosomal, genetic, or structural anomaly * Fetal growth restriction, or birth weight \< 10th centile * Birth weight \> 90th centile or polyhydramnios in the controls * Non-reassuring fetal status requiring immediate treatment, or intrauterine fetal demise * Verified fetal infection (e.g. cytomegalovirus, toxoplasma, hepatitis B and C), excluding bacterial infection due to intrapartum chorioamnionitis * Placenta accreta spectrum disorder * Major maternal medical condition requiring systemic pharmacological treatment, other than non-severe hypertension, hypothyroidism, asthma, mild psychiatric disorders, etc. * Alcohol or tobacco use, or substance abuse in pregnancy

Locations (2)

Turku University Hospital
Turku, Finland
Turku University Hospital
Turku, Finland